07 / Inzymes ApS
Inzymes ApS
Named in 1 published report.
Standing description
Inzymes ApS is named in 1 published Cell-Ag report. The arrangement joins a portfolio that includes recombinant bovine chymosin commercialized with Inzymes ApS and recombinant bovine alpha-lactalbumin being developed alongside BRIG BIO, according to the publication. Our coverage files it under Fermentation, Manufacturing.
Assembled from our own published reporting. Nothing here is sourced elsewhere.
Coverage, newest first
4 August 2026
Dyadic signs European license deal for precision-fermented dairy proteins
The arrangement joins a portfolio that includes recombinant bovine chymosin commercialized with Inzymes ApS and recombinant bovine alpha-lactalbumin being developed alongside BRIG BIO, according to the publication.